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Abstract
Background: Parastomal hernia (PSH) can be repaired surgically, but results to date have been disappointing, with
reported recurrence rates of 30 to 76%. Other types of intervention are therefore needed to improve the quality of
life of people with PSH. One potential intervention is physical activity. We hypothesise that the intervention will
increase core activation and control across the abdominal wall at a site of potential weakness and thus reduce the
risk of PSH progression. Increases in physical activity will improve body image and quality of life (QoL).
Methods: Subjects and sample
There were approximately 20 adults with a bowel stoma and PSH. People with previous PSH repair will be excluded
as well as people who already do core training.
Study design
This is a feasibility study of a randomised controlled trial with 2 months follow-up, in 2 sites using mixed methods.
Stage 1 involves intervention development and in stage 2, intervention and trial parameters will be assessed.
Intervention
A theoretically informed physical activity intervention was done, targeting people with PSH.
Main outcome of feasibility study
The main outcome is the decision by an independent Study Steering Committee whether to proceed to a full
randomised controlled trial of the intervention.
Other outcomes
We will evaluate 4 intervention parameters—fidelity, adherence, acceptability and safety and 3 trial parameters
(Continued on next page)
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: Gill.hubbard@uhi.ac.uk
1Department of Nursing and Midwifery, University of the Highlands and
Islands, Centre for Health Science, Old Perth Road, Inverness IV2 3JH, UK
Full list of author information is available at the end of the article
Hubbard et al. Pilot and Feasibility Studies           (2020) 6:142 
https://doi.org/10.1186/s40814-020-00674-2
(Continued from previous page)
(eligible patients’ consent rate, acceptability of study design and data availability rates for following endpoints):
I. Diagnosis and classification of PSH
II. Muscle activation
III. Body composition (BMI, waist circumference)
IV. Patient reported outcomes: QoL, body image and physical functioning
V. Physical activity;
VI. Psychological determinants of physical activity
Other data
Included are other data such as interviews with all participants about the intervention and trial procedures.
Data analysis and statistical power
As this is a feasibility study, the quantitative data will be analysed using descriptive statistics. Audio-recorded
qualitative data from interviews will be transcribed verbatim and analysed thematically.
Discussion: The feasibility and acceptability of key intervention and trial parameters will be used to decide whether to
proceed to a full trial of the intervention, which aims to improve body image, quality of life and PSH progression.
Trial registration: ISRCTN15207595
Keywords: Parastomal hernia, Colostomy, Ileostomy, Bowel disease, Feasibility study
Background
Parastomal hernia
Parastomal hernia (PSH) is a common problem following
stoma formation [1, 2], with prevalence estimates over
30% by 12months, 40% by 2 years and 50% or higher at
longer duration of follow-up [3]. A cross-sectional study
of 75 patients with an end colostomy for ≥ 1 year found
that 33 (44%) had evidence of a PSH on computerised
tomography (CT) [4]. The majority of these patients were
symptomatic (27 versus 6), such as pain or difficulties with
stoma appliance and able to identify the moment of clin-
ical appearance of the PSH, which occurred within 8
months of surgery [4].
One of the functions of deep abdominal muscles is to
provide support to the abdominal region and the spine by
forming a muscle band that tightens like a corset [5]. Fol-
lowing abdominal surgery, the physiology of the abdom-
inal wall is altered with damage to nerve supply and
atrophy of the midline muscular wall [6]. Surgery for cre-
ating a stoma alters the physiology in the same way and
creates a further site of weakness by leaving a hole in the
abdominal wall. Evidence indicates that there is muscular
atrophy directly below the stoma site, resulting in change
of forces and pressure on the abdominal wall [7].
There is a paucity of prospective data about the nat-
ural history and trajectory of PSH and whether PSH se-
verity progression can be arrested [8, 9]. PSH can be
repaired surgically but results to date have been disap-
pointing, with reported recurrence rates of 30 to 76%
[10]. The effectiveness of prophylactic synthetic mesh at
the time of stoma formation for the prevention of PSH
also remains uncertain [10]. Hence, other types of
intervention are needed to improve the QoL of people
with PSH. One potential intervention is physical activity.
People with a stoma have identified PSH and physical
activity as top research priorities in relation to their
quality of life (QoL) [11]. Studies highlight a trend to-
ward inactivity after stoma formation surgery, with fear
of PSH being a major deterrent to being physically active
[12–14]. Both patient and surgical factors influence the
risk of developing PSH [15]. Patient risk factors include
high body mass index (BMI) [8, 16, 17], waist circumfer-
ence [18] and low levels of physical activity [19, 20].
PSH is associated with poor body image (a psychological
construct that captures the perceptions, emotions, and
attitudes a person holds towards his/her own body [21]),
and both PSH and poor body image are associated with
poor general QoL [20, 22–26] and poor physical func-
tioning [24, 25].
Physical activity and parastomal hernia
To our knowledge, no physical activity intervention
studies have been conducted that specifically target
people with PSH. We hypothesise (see Fig. 1; logic
model) that a physical activity intervention, that includes
deep core muscle training, will elicit an adaptation re-
sponse to re-engage muscle activation and control to
provide an improved deep ‘corset’ support of the abdom-
inal wall, thereby reducing the risk of PSH progression.
Evidence shows that core activation leads to thickening
on the abdominal muscles and a decrease in the cross-
sectional area of the trunk (p < 0.001) [5] and that core
training can lead to muscle thickening [27]. We also be-
lieve that a physical activity intervention will reduce the
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risk of PSH progression by effecting known risk factors
for PSH such as BMI and low levels of physical activity.
There is no published research about the effect of
physical activity in people with a stoma; hence, this hy-
pothesis is based on evidence cited above as well as from
systematic reviews and meta-analysis of the benefits of
physical activity in the general population [28, 29]. For
example, a systematic review of 10 studies (6 rando-
mised controlled trials and 4 uncontrolled trials), involv-
ing people aged 60 to 80 years, of the effects of Pilates
exercise training reported a large effect size (ES) to im-
prove muscle strength (ES = 1.23), walking and gait per-
formances (ES = 1.39), activities of daily living, mood
states and QoL (ES = 0.94), moderate to high effect on
dynamic balance (ES = 0.77), and small effects on static
balance (ES = 0.34) and flexibility (ES = 0.31) [30]. A
meta-analysis of 57 exercise interventions (mean age
30.4 years; standard deviation 15.35, range 10.02 to
63.40) reported that exercise resulted in improved body
image from pre- to post-intervention for the interven-
tion group compared with a control group with the lar-
gest effects evidence for adults (mean ES = 0.44) and
older adults (mean ES = 033) [31].
However, before embarking on a full trial to test the
hypothesis, a feasibility study of the proposed physical
activity intervention and trial procedures is needed.
Feasibility studies
The Medical Research Council framework for the devel-
opment of complex interventions highlights that a key
element of the development and evaluation process is
feasibility work prior to assessing effectiveness [32]. It is
generally recommended that feasibility studies descrip-
tively evaluate a trial’s feasibility, acceptability and safety
rather than test the effectiveness of the hypotheses of
the planned main large-scale trial [33]. Feasibility studies
are therefore conducted to assess key intervention and
trial parameters to improve the rigor of a future full trial.
In feasibility studies for instance, intervention fidelity
and intervention adherence may be assessed because
they can impact on statistical power and interpretation
of trial results, including underestimating any efficacy in
a full trial. However, a challenge for assessing these key
parameters is that there is no consensus on the accept-
able minimum fidelity or adherence level in trials and no
standardised approach to their definition and measure-
ment in the field of complex interventions [34, 35]. A re-
cent review of how to define and measure adherence in
studies examining older adults’ participation in exercise
classes for instance, suggests adherence is defined and
measured in a variety of ways with different cut-off
points for indicating if adherence is successful [36].
Aims
The aim of this feasibility study is to evaluate 4 interven-
tion parameters—fidelity, adherence, acceptability and
safety and 3 trial parameters, namely eligible patients’
consent rate, acceptability of study design (i.e., rando-
mised controlled trial), and data availability rates for
measuring the following endpoints (i.e., mechanisms and
outcomes (see Fig. 1)) pre- and post-intervention:
I. Diagnosis and classification of PSH
II. Muscle activation
III. Body composition (BMI, waist circumference)
IV. Patient reported outcomes: QoL, body image and
physical functioning
V. Physical activity
Fig. 1 Logic model
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VI. Psychological determinants of physical activity
The aim of the future trial is to determine whether a
structured physical activity intervention that includes
core training and signposting to written guidance about
physical activity in people who have bowel stoma and
have PSH improves outcomes in comparison with sign-
posting to written guidance only.
Methods
Project design
This is a feasibility study of a randomised controlled trial
with 2months follow-up, in 2 sites, with 20 participants,
using mixed methods. Stage 1 involves intervention de-
velopment and in stage 2, intervention and trial parame-
ters will be assessed.
Stage 1: intervention development
The research team have already developed a physical ac-
tivity intervention for people with stoma [37] and pro-
duced an intervention manual for physical activity
instructors supporting people with stoma to engage in
physical activity [38]. In this study, the research team
will develop new materials for people who have PSH, in-
cluding videos to demonstrate exercises for re-engaging
the body core and abdominal muscles and instructions
on techniques and breathing for these exercises. A peer
review group comprising exercise experts, physiothera-
pists and stoma nurse specialists will advise the research
team during the development of these materials. The
planned intervention is described below using the Tem-
plate for Intervention Description and Replication
(TIDieR) sub-headings and guidance, which is a generic
template for behaviour change interventions [39]:
Why—theory and components
We hypothesise that a physical activity intervention that
includes core training will elicit an adaptation response
in the core muscles to re-engage muscle activation and
control to provide an improved deep ‘corset’ support of
the abdominal wall thereby reducing the risk of PSH
progression. We also believe that a physical activity
intervention will reduce the risk of PSH progression by
effecting known risk factors for PSH, such as BMI and
low levels of physical activity. The intervention is based
on Self-Determination Theory [40] which focuses on
maintaining the motivation to be physically active by
making sure that participants have ‘autonomy’ (e.g., by
offering a choice of different types of core body exer-
cises), are ‘competent’ (e.g., by being shown how to
lower intra-abdominal pressure during exercise) and ex-
perience ‘relatedness’ (e.g., by recognising their fears of
worsening their bulge/PSH through exercise) [41].
What—materials
The exercise instructor will use the manual (i). Partici-
pants will be given materials that include videos demon-
strating exercises for activating the body core and
abdominal muscles and instructions on techniques and
breathing for these exercises (ii). Participants will be
given a biofeedback stabiliser to monitor and hence,
regulate intra-abdominal pressure and risk of injury (iii).
What—procedures
The intervention will involve participants having 12 (1 per
week) consultations with an exercise instructor. Profes-
sional associations for exercise specialists, such as the UK
Chartered Institute for the Management of Sport and
Physical Activity acknowledge that pre-exercise screening
is an important part of the duties of an exercise specialist.
Hence, the instructor will use the Physical Activity Readi-
ness Questionnaire (PARQ) long version [42] so that she
can prescribe an individualised exercise programme for
each participant, taking account of medical history and
current health status. Participants will be prescribed 4 dif-
ferent types of core training exercises with 4 levels of pro-
gression. These exercises are based on the Australian
Physiotherapy and Pilates Institute methods programme
[43]. Over the 12-week programme, there will be gradual
progression in the prescribed frequency (number of times
to perform the exercises that week), intensity (rate of exer-
tion to perform the exercise that week) and duration (mi-
nutes to perform these exercises).
The exercises will conform with the new guidelines is-
sued by the American College of Sports Medicine for
people with an ostomy appliance [44]. Gradual progres-
sion also reduces the risk of participants over-exerting
themselves with exercising and causing injury.
Who provides, how and where
Participants will receive a weekly physical activity consult-
ation from an exercise instructor in-person, telephone and
by video conferencing. The instructor will have as a mini-
mum a Register of Exercise Professionals Level 4 recog-
nised qualification (the instructor in this study for
instance, has a cancer rehabilitation Level 4 qualification,
and has a stoma and therefore has direct personal experi-
ence). All exercises are completed at home.
When and how much
The intervention is of 12 weeks duration. Each partici-
pant will receive a weekly consultation. The duration of
each weekly consultation is likely to vary; based on our
previous study, the average range is likely to be 15–45
min (min 5; max 120; median 35).
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Stage 2: feasibility study
Setting
Participants will be recruited from two hospitals in a Na-
tional Health Service Trust/Board: Raigmore Hospital in
NHS Highland (Scotland) and St James Hospital in
Leeds Teaching Hospitals NHS Trust (England).
Eligibility criteria
PSH can give a person a bulge around the stoma, but
some bulges do not correspond to PSH, which is an ab-
normal protrusion of the contents of the abdominal cavity
through the abdominal wall defect created during place-
ment of a colostomy, ileostomy or ileal conduit stoma
[45]. Hence, adults 16 years+ (in the UK, for the purposes
of research, people 16 years old and over are adults [46]);
≥ 3months post stoma formation surgery for bowel dis-
ease (e.g., inflammatory bowel disease, colorectal cancer)
with a colostomy or ileostomy who perceive that they have
a bulge or PSH or who have a clinical diagnosis of PSH
will be eligible. People who are already doing core training
(e.g., Pilates, yoga) will be excluded. People with previous
PSH repair will be excluded.
Intervention and comparator group
Participants randomly allocated to the intervention
group will receive the physical activity intervention as
described above and signposted to information and guid-
ance about physical activity that are provided by UK
relevant charities including Ileostomy and Internal
Pouch Association and Colostomy UK. If allocated to
the control group, participants will be signposted to the
same guidance about physical activity.
Main outcome of feasibility study
The main outcome of this feasibility study is a decision
by an independent Study Steering Committee to proceed
to a full trial using the following traffic light system to
guide decision-making (Table 1).
Intervention measures and data collection
The following measures and data collection methods will
be used to assess intervention parameters:
Intervention fidelity
Intervention fidelity is defined as the extent to which
the intervention is delivered as intended by the exercise
instructor [34]. The exercise instructor will record for
each participant the number of consultations, duration
and medium (e.g., face-to-face; video call; telephone
call). Based on our previous study of a physical activity
intervention for people with stoma [47], we estimate that
the mean number of consultations will be 10 and mean
duration approximately 35 min (mean duration per par-
ticipant over 12 weeks is 322 min). The instructor will
also keep a record of the exercise prescription each
week, and make summary notes throughout the 12-week
programme.
Intervention adherence
All exercises are completed at home. Intervention ad-
herence is defined as the completion rate of the pre-
scribed exercises by participants [36]. Participants will
write down in a physical activity diary the frequency, in-
tensity and duration of doing the core training exercises
that are prescribed by the exercise instructor in a diary
that they will complete each week for the 12-week dur-
ation. They will also record other types of leisure time
physical activities that they do such as running, walking
and swimming. Each day of the week, participants will
report each type of exercise, their rate of perceived exer-
tion using the Borg RPE Scale [48]. If more than one ex-
ercise is done in a given day, a separate row is used to
record each individual activity.
A continuous rating scale will be used to assess partic-
ipants’ adherence to the prescribed exercises. At the end
of each week, participants will answer the following
question:
‘On a scale of 0 to 10, how successful were you at
completing the prescribed exercises? When answering
this question think about your success in relation to the
prescribed frequency, intensity and duration. A score of
10 indicates 100% successful.’
A free text box will be included in the diary so that
participants can report any challenges and barriers that
they encountered while performing the prescribed
exercises.
Intervention acceptability
At the end of the study, participants will report on a
continuous rating scale of 0 to 100 if the intervention
was acceptable for self-managing their bulge/PSH, with
a higher score indicating that the intervention was ex-
tremely useful.
The acceptability of the intervention will also be ex-
plored at the end of the study through semi-structured
face-to-face or telephone interviews (depending on par-
ticipant preference) with participants. A semi-structured
interview is chosen as it allows flexibility with sequen-
cing of questions and for following up on any topics that
arise naturally through discussion [49]. These interviews
will last approximately 30 min and cover participants’
opinions on perceived challenges and barriers to being
physically active, content of the intervention, and its per-
ceived relevance and usefulness in self-managing bulge/
PSH. These interviews will also be used to gather partici-
pants’ opinions of trial procedures.
Intervention safety
There is no validated patient-reported or clinically
relevant measure of discomfort or pain while exercising
for people with PSH. Hence, a 10-point continuous rat-
ing scale that we have developed will be used to assess
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participants’ level of discomfort and pain while perform-
ing the prescribed exercises. Participants are advised of
the potential for post-exercise pain and discomfort in
the trial documentation. At the end of each week of the
12-week programme, participants will answer the follow-
ing question:
‘On a scale of 0 to 10, how much discomfort and pain
did you experience around your stoma and bulge/PSH
when doing the prescribed exercises? A score of 0 indi-
cates no discomfort or pain.’
Mean discomfort/pain scores for exercises over the
12-week period will be calculated. Adverse events (AEs)
will be reported as part of the ethical conduct of the
study as described below.
The topic of potential discomfort and pain while exer-
cising will be discussed with participants at in-depth in-
terviews. In addition, as a standard part of most
consultations, participants will discuss how they have
found the exercises in the previous week.
Trial measures and data collection
The following measures and data collection methods will
be used to assess trial feasibility and acceptability:
Eligible patients’ consent rate
We will assess eligible patients’ consent rate at each
hospital site. A researcher will record the number of eli-
gible patients who consent to the study. Based on our
previous study of a physical activity intervention for
Table 1 Criteria for progression from feasibility to efficacy trial
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people with stoma [47] and people with bowel cancer
[50], we estimate a 30% consent rate.
Acceptability of randomised controlled design
Eligible patients’ consent rate and the retention rate
for the study will be used as proxies for acceptability of
a randomised controlled trial design. The retention rate
is defined as the number of consenting participants who
complete baseline and follow-up measures. Based on our
previous study of a physical activity intervention for
people with stoma [47], we estimate a 60% retention
rate.
Acceptability and data availability of outcome
measures
The acceptability of measures of outcomes will be ex-
plored in the semi-structured interviews conducted with
participants at the end of the study (see above). Data
availability refers to the amount of data available for ana-
lyses. In a future fully powered trial, only complete data
(i.e., individually paired baseline and follow-up data for
the primary outcomes) will be included in the analyses.
In this feasibility study, we will therefore assess the
amount of complete data for endpoints and other out-
comes (Table 2).
Diagnosis and classification of bulge/PSH
Documentation of the size of a bulge/PSH and
changes over time will be assessed by clinical examin-
ation. There is no gold standard examination to assess,
diagnose and classify PSH [3]. CT is highly accurate at
identifying PSH but is difficult to justify because of cost,
and there is risk of radiation exposure. A radiologist and
medical physicist in one of the research sites had ethical
concerns about increased radiation exposure, particu-
larly in young adult participants with inflammatory
bowel disease (IBD). They also were not confident that
there was capacity to meet the study’s baseline and
follow-up timepoints due to pressure on this resource
for clinical purposes. Hence, it was decided to use clin-
ical examination to diagnose and classify bulge/PSH.
Clinical examination has sensitivity rates between 66
and 94%, and specificity rates are reported to be as high
as 100% [3]. The grade of PSH will be recorded using a
classification system recommended by the European
Hernia Society [3, 45]. Each participant will have a clin-
ical examination by a member of their clinical team (e.g.,
surgeon or nurse).
As illustrated in Fig. 1, we hypothesise that the PA
intervention will lead to improved muscle activation,
prevent muscle atrophy in the stoma area, and improve
muscle density via activation and control. We also hy-
pothesise that patient-level risk factors such as BMI and
waist circumference will be reduced by the PA
intervention.
Muscle activation
Any changes to muscle activation will be assessed
using electromyography (EMG) to record the electrical
activity of the abdominal muscles [51]. The EMG will
record the electrical activation of the cells to demon-
strate the level of contraction achieved.
Body composition
An abdominal CT scan would allow assessment of the
physiological changes and body composition because it
would enable calculation of abdominal muscle density
and abdominal muscle/adipose tissue ratio by analysing
the L3 lumbar muscle segments of each participant. Ab-
dominal circumference measurements and assessment of
abdominal adiposity can similarly be calculated. How-
ever, as described in the previous section, a decision to
not use a CT scan in this study was made. The following
non-invasive methods for measuring body composition
will therefore be adopted instead:
Waist circumference will be measured by a researcher
who will receive written and pictorial instructions on
proper performance of the measurement [52]. All mea-
surements will be performed using the MyoTape (Accu-
Fitness, LLC) on bare skin or over thin garments. BMI is
an easily calculated assessment of body weight adjusted
for height (weight in kilograms/height in metres). Body
weight (kg) will be measured by a researcher using
TANITA scales. Patients will be asked to remove any
outer garments, take off shoes and empty pockets. Stadi-
ometers will be used to measure height (cm). Patients
will be instructed to remove their shoes, stand with feet
flat on the floor, feet together and heels against the wall,
and with shoulder blades and buttocks also touching the
wall, arms hanging loosely by their side, and facing
straight ahead. They will be instructed to breathe in
deeply and stretch to their fullest height when the meas-
urement is taken. BMI will be calculated from these
measurements using the standard formula of weight
(kg)/height (m)2. BMI scores can then be translated into
Table 2 Endpoints and measures
Outcomes Measures
Diagnosis and classification of
PSH
• Clinical examination
Muscle activation • Electromyography (EMG)
Body composition
Waist circumference
BMI
• Measuring tape
• TANITA scales (weight) and
stadiometer (height)
Patient reported outcomes
QoL
Body image
Physical functioning
• Stoma-QoL and EQ-5D
• Body image scale
• Patient specific function scale
Physical activity • Actigraph GT3X+ accelerometer
Psychological determinants of
physical activity
• Basic psychological needs in
exercise scale
• Exercise self-efficacy
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the following categories underweight, normal weight,
overweight or obese.
Patient reported outcomes: quality of life, body
image and physical functioning
In a future full-scale trial, we intend for QoL to be the
primary outcome; this variable provides us with the pa-
tient perspective of the intervention’s direct clinical
benefit and is an outcome that is considered important
to patients [53]. To our knowledge, there are no bespoke
instruments for assessing PSH-related QoL or for body
image in this group. There are, however, generic QoL
and body image instruments and several stoma-specific
QoL tools [54] that we will use. PSH-specific questions
will be incorporated. We will use the following instru-
ments that will be completed by participants at baseline
and follow-up. Each participant will meet with a re-
searcher face to face to complete questionnaires hosted
by Bristol On-line Survey, which is an online service that
allows researchers to develop, deploy and analyse an on-
line survey. Which instruments we use in the planned
full trial will be decided by the independent Study Steer-
ing Committee (see Main outcome of feasibility section)
who will draw on completion rates for each measure
alongside qualitative data from participant interviews
about the relevance and acceptability of each measure to
make an informed decision.
The generic QoL instrument that we will use is the
European Quality of Life-5 Dimensions (EQ-5D-5L),
which is common measure of health-related quality of
life [55]. It is divided into two sections: the EQ-5D index
and the EQ thermometer. The EQ-5D index assesses
health across five domains: mobility, self-care, usual ac-
tivities, pain/discomfort and anxiety/depression. The EQ
thermometer is a single 20-cm vertical visual analogue
scales with a range of 0 to 100, where 0 is the worst and
100 is the best imaginable health and is completed by
the user for their current health. Descriptive data from
the five dimensions of the EQ-5D part 1 can be used to
generate a health-related quality-of-life profile for the
subject, created from the 1–5 scale for each question.
This can be further divided into those reporting ‘prob-
lems’ or ‘no problems’, combining some of the subscales.
Part 2 is scored from 0 (worst health state imaginable)
to 100 (best health state imaginable). The score from
part 2 can be used to track changes in health, on an in-
dividual or group level, over time. Simulation-based esti-
mates (mean score) of the minimal important difference
(MID) of the EQ-5D-5L index score in 6 countries (in-
cluding England) were generally between 0.037 and
0.069, which are similar to the MID estimates of other
preference-based QoL measures [56]. The MID (mean
and standard deviation) for England was 0.037 ± 0.008).
Stoma-related QoL will be measured using the Stoma-
QoL [57], which was deemed acceptable for use by
participants in our previous study [37]. It is a 21-item
questionnaire; 19 items covering the 5 domains of work/
social functioning, sexual/body image, stoma function,
financial concerns, and skin irritation are scored using a
5-point Likert-type frequency scale, and 2 items measure
overall life satisfaction and are scored from 0 to 100,
with 0 being the worst possible score and 100 being the
best score. To our knowledge, no recommended MID
estimates have been published for this instrument.
The body image scale [58] will be used for assessing
body image. It was chosen because it has been validated
in ostomy patients [59]. It is a 10-item questionnaire
with items scored using a 4-point rating scale that was
developed to assess the affective (e.g., feeling self-
conscious), behavioural (e.g., difficulty in looking at the
naked body) and cognitive (e.g., satisfaction with appear-
ance) aspects of body image in cancer patients.
The Patient-Specific Functional Scale (PSFS) focuses
on the patient’s opinion of their function in order to
provide clinicians with a reliable and valid self-reported
outcome measure [60]. The patient lists up to five activ-
ities that are limited by their condition (in this study,
bulge/PSH) for which they are seeking treatment (in this
study exercise programme). For each activity, patients
use a continuous rating scale (0 to 10) with a lower score
indicating that they are unable to perform the activity, to
indicate the extent to which they are able to carry out
the activity. The total score is the sum of the activity
scores divided by the number of activities listed. It takes
an average of 4 min to complete. It is used in clinical
practice and research to assess if there is a meaningful
change in functional status that has occurred over time.
The MID has been evaluated for certain conditions and
is between 2 and 3 [60].
Physical activity
The amount of physical activity will be objectively mea-
sured using the Actigraph GT3X+ accelerometer (Acti-
graph LLC, Pensacola, FL, USA) [61]. Accelerometers
record movement in such a way that it can be translated
into a number of different outputs, for example total step
count, bouts of physical activity at specified intensities or
energy expenditure. This measure will be used to examine
how physical activity levels change over the course of the
study. It will be worn around the wrist and measures
activity counts, steps, inclinometers, and light and
moderate-to-very-vigorous physical activities. Participants
will be given an accelerometer that will be worn during
waking hours for 7 consecutive days for 1 week at baseline
and follow-up. At the end of the 7-day period, participants
will return the device to the research team.
Accelerometer devices will be initialised by a re-
searcher as follows: (1) Device recording of physical ac-
tivity will be set for 7 days, with the intention to gain a
minimum of 4 valid days of data for each participant; (2)
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the date and time when the participant is scheduled to
wear the device will be set. The sample rate will be set
to 30 Hz; (3) the unique participant ID will be added to
the specific device.
Once the device is returned by a participant, the Acti-
graph software will be used to download data, as follows:
(1) The unit of measurement will be set at 10-s epochs;
(2) the ‘# of axis’ setting will be set to 3, and ‘steps’, ‘lux’,
‘inclinometer’ and ‘low frequency extension’ will all be
selected. The Actigraph software wear-time validation
will be set to meet the following criteria: (1) minimum
number of valid days required = 4; (2) non-wear time
will be set at > 60 min of consecutive zeros; (3) mini-
mum number of wear hours per day required will be set
at > 10 h (600 min). Commonly reported cut-points for
adults will be used to differentiate physical activity inten-
sity using Freedson et al. [61].
Psychological determinants of physical activity
The Basic Psychological Needs in Exercise Scale as-
sesses [62] determinants of physical activity from the
perspective of the self-determination theory, which is
the theory underpinning the intervention [41]. This is an
11-item self-report questionnaire. Participants rate each
item on a 5-point scale from 1 (I don’t agree at all) to 5
(I completely agree). Items assess participants’ need ful-
filment for autonomy, competence and relatedness. In
line with the self-determination theory, the satisfaction
of these needs results in higher levels of behavioural
self-determination that in turn, is reflected by higher
levels of, for example, intrinsic motivation (e.g., finding
exercise enjoyable) and identified regulation (e.g., con-
sidering exercise outcomes to be personally important).
Participant timeline
Figure 2 illustrates the process of enrolling participants in
the study and timing of intervention and measurements.
Sample size and randomisation
The current study will confirm the feasibility of recruit-
ing and retaining patients with stoma based on the rates
obtained from our previous physical activity trial in this
sample as outlined above. In a future full-scale trial, we
intend for QoL to be our primary outcome; based upon
the review above [30], we anticipate a large effect size.
Therefore, in line with Whitehead et al., a sample size of
20 is appropriate [63].
Participants will be randomly allocated to intervention
and control groups by a researcher using MinimPy
(http://minimpy.sourceforge.net/introduction.html),
which is a free randomisation software package to man-
age the process of minimizing the difference among trial
groups with respect to preselected categorical factors,
i.e., age and gender.
Recruitment and consent
Two recruitment methods that we have tested in our
previous study [47] have been chosen for this study be-
cause they will maximise recruitment. The number of
patients recruited by each method will be compared.
Hospital
A list of potentially eligible patients will be put to-
gether by the hospital clinical team who will send a let-
ter of invitation to those that are eligible. Patients who
are interested in the study will get in touch with the re-
search team by post, telephone, or email expressing an
interest in the study. A researcher will contact the po-
tential participant by email or telephone to explain the
study in more detail and confirm eligibility. Written in-
formation, in the form of a participant information sheet
(PIS), will be sent to potential participants. The PIS will
describe the nature of the study, what it will involve, and
the known risks of taking part. Written informed con-
sent will be obtained at a face-to-face meeting that will
be arranged to coincide with the administration of base-
line measures.
Social media
Recruitment via social media will also be used to maxi-
mise recruitment numbers. An advertisement about the
study will be disseminated by members of the Patient
Advisory Group and by relevant stoma charities (Ileos-
tomy and Internal Pouch Association, Colostomy UK)
on both Facebook and Twitter. Contact details of the re-
search team will be provided, along with brief eligibility
criteria. This will allow anyone who is interested in tak-
ing part to see if they will be eligible and to contact the
research team directly. As above, the participant will be
contacted by email or telephone and sent a PIS, and
written informed consent will be obtained.
Data analysis
Intervention parameters (fidelity, adherence, acceptabil-
ity and safety) and trial parameters (eligible patients’
consent, retention and data availability rates) will be re-
ported overall and by site. Reasons for non-fidelity, non-
adherence, non-consent, non-randomisation, and non-
availability of data will be summarised. Follow-up rates
will be reported overall, by site and by arm to demon-
strate the acceptability of the schedule for both arms.
The analysis will focus on confidence interval estimation
rather than formal hypothesis testing. All outcome mea-
sures will be summarised by arm, at each time point to-
gether with 95% confidence intervals. Levels of missing
data for all outcomes will be summarised overall and by
arm. AEs will be monitored and rates compared descrip-
tively between study groups. Qualitative thematic ana-
lyses of audio-recorded interviews and focus groups will
be conducted using the Framework approach [64]. These
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data will inform the decision to proceed to a Phase III
trial (Table 1).
Ethical considerations
The research study has been approved by the North of
Scotland Research Ethics Committee (REC REF 20/NS/
0007).
Consent
The ethical principles of ensuring freely given fully in-
formed consent and the right to withdraw from research
participation will apply. The right to anonymity when
reporting findings will be emphasised.
Confidentiality
All participants will be informed that all of the informa-
tion that they provide to the research team will remain
confidential and will only be accessible to members of
that team. Only personal information that is deemed
vital for running this study will be obtained. Participants
will be given a unique study identifier so that their name
will be filtered out of any quantitative and qualitative
datasets used for analysis. The clinical exercise instructor
delivering the intervention will sign a confidentiality
agreement with the University of the Highlands and
Islands (study sponsor), and patients will provide in-
formed consent of their basic demographic details and
relevant medical history provided for the instructor.
Participant risk
Any exercise carries a risk of injury. To minimise this
risk, the clinical exercise instructor will use the Physical
Activity Readiness Questionnaire (PARQ) long version
[42] so that she can prescribe an individualised exercise
programme for each participant, taking account of med-
ical history and current health status. We will ensure
that the following recommendations by the UK Associ-
ation of Stoma Care Nurses (ASCN) and American Col-
lege of Sports Medicine (ACSM) are brought to the
attention of the clinical exercise instructor delivering the
PA intervention in this feasibility study. ACSN recom-
mend core muscle exercises to strengthen the abdominis
in order to prevent parastomal hernia formation. How-
ever, ASCN also advises against lifting heavy objects
during stoma formation recovery since this may increase
the risk of a parastomal hernia during the post-operative
Patients assessed for eligibility (n = )
Adults with a bowel stoma and bulge/PSH
Patients recruited (n=20)
Excluded (n= )
Arm 1
Structured physical activity intervention (n =10)
Baseline measures 
Did not complete (n=)
Follow up measures (n = ); 
Lost to follow up (reasons given (n = )
Analysis (n= )
Excluded from analysis (reasons given (n= )
Interviews  (n=10)
Excluded (n= )
Reasons:
Analysis (n= )
Excluded from analysis (reasons given (n= )
Follow up measures (n = ); 
Lost to follow up (reasons given (n = )
Randomisation (n= )
Arm 2
Signposted to physical activity written guidance (n = 10)
Interviews  (n=10)
Fig. 2 Participant flowchart
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recovery period [65]. The new cancer and exercise
American College of Sports Medicine guidelines are as
follows:
 Empty ostomy bag before starting exercise.
 Weight lifting/resistance exercises should start with
low resistance and progress slowly under the
guidance of trained exercise professionals. People
with an ostomy may be at an increased risk of
parastomal hernia. To regulate intra-abdominal
pressure, correct lifting technique and good form is
required. Avoid use of a Valsalva maneuver.
 Modify any core exercises which cause excessive
intra-abdominal pressure, namely a feeling of pres-
sure or observed bulging of the abdomen.
 Those with an ileostomy are at increased risk of
dehydration. Get medical advice on ways to
maintain optimum hydration prior, during and after
exercise.
 Those doing contact sports or where there is a risk
of a blow to the ostomy may wish to wear an
ostomy protector/shield.
Safety reporting
The AE reporting procedures will follow those of NHS
guidelines for research trials [66]. All participants will be
advised and encouraged to report concerns to the re-
search team, their stoma nurse and the clinical exercise
instructor. All serious adverse events (SAE) and AEs will
be recorded regardless of whether they are related to
participation in the physical activity intervention and
sent to the Chief Investigator who will use the NHS rec-
ommended form [66] to report the SAE to the Research
and Ethical Committee that approved the study.
Data management
Data will be kept in accordance with the Data Protection
Act. The study includes four paper report forms: (i) Re-
searchers in each site will complete a ‘recruitment form’
that will include number of eligible patients, the consent
rate and reasons for declining participation; (ii) the clin-
ical exercise instructor will complete a ‘consultation
form’ indicating number, duration and type of consult-
ation; (iii) participants will complete a diary to record
prescribed activities; (iv) the study also includes the re-
sults of the clinical examination PSH classification and
body composition. A researcher will remove patient
names from any of these paper forms and replace with a
unique identifier. Data on these paper report forms will
be manually entered by a researcher into customised
password encrypted spreadsheets in Microsoft Excel. A
researcher will export all data entered into Microsoft
Excel and Bristol Online Survey to the Statistical Pack-
age for the Social Sciences v19.0 for the purposes of
analysis. All electronic data will be retained on a univer-
sity password-protected server, and all paper records will
be retained in a secure storage facility on university
premises for a minimum of 10 years.
Governance
The study will be conducted in accordance with the
current protocol. A Study Steering Committee will pro-
vide overall supervision of the study on behalf of the
study sponsor and the funder to ensure the study is con-
ducted to the standards set out in the UK Framework
for Health and Social Care Research (version 3, 2017).
As noted above, the committee will make the decision
whether the research team should proceed to a full trial.
It will comprise senior clinicians and academics with re-
search expertise in this area. The Study Management
Group will be responsible for ensuring that the protocol
is adhered to and will comprise the Chief Investigator,
Researcher Assistants and the other investigators.
Patient and public involvement
A Patient Advisory Group for a previous study [37] that
included 10 people with stoma has already been involved
in designing this study and will continue to be involved
in this new study by, for example, developing patient in-
formation sheets and using social media to assist in
recruitment.
Discussion and dissemination
We will conduct a feasibility randomised controlled trial
of a physical activity intervention in people who perceive
that they have a bulge/PSH to improve QoL and other
patient-reported and clinically meaningful outcomes.
The feasibility and acceptability of key intervention and
trial parameters will be used to decide whether to
proceed to a full trial of the intervention. The findings
from this feasibility study will be shared with interested
parties and audiences on national and international
levels. The intention of this feasibility study is to inform
a full randomised controlled trial, and any outcome and
finding from this preliminary work will be disseminated
on that basis.
Nevertheless, we acknowledge that results from feasi-
bility or pilot studies to estimate recruitment, random-
isation and attrition rates for a full trial should be used
with caution. A recent review of publicly funded trials
that compared the difference in the rates between pilots
and their associated full trial found high variability and
therefore recommended the use of internal pilot trials
[67]. Hence, we will include an internal pilot in any fu-
ture trial should a decision from this feasibility study be
to proceed.
To the best of our knowledge, this is the first physical
activity intervention study to improve QoL in people
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with bowel stoma who perceive that they have PSH. The
intervention, if effective, could be relevant to a large
number of patients; one study reported a prevalence of
PSH in up to 78%, detected either clinically or by CT
[68]. Further, if the intervention halts bulge/PSH pro-
gression, then this would be clinically significant and
may halt the progression of symptomatic hernias causing
pain, discomfort and problems with the fitting and func-
tion of the stoma appliance [4].
We are aware of very few physical activity intervention
studies involving people with stoma. Previous studies
aimed to prevent PSH as opposed to supporting people
to self-manage a bulge/PSH. Thompson and Trainor’s
landmark studies in 2005 and 2007 evaluated an inter-
vention that used three components—awareness of PSH,
abdominal exercises, use of support belts during heavy
lifting—for 1 year post-operatively to prevent a PSH
[69]. They recruited a cohort in year one (n = 87) who
did not receive the intervention and a cohort in year two
(n = 114) and three (n = 99) who received the interven-
tion, and subsequently compared PSH incidence be-
tween the three cohorts. They found PSH incidence was
28%, 14% and 17% in the year one, two and three co-
horts, respectively, and found a statistically significant
difference between year one and two incidences but not
between years one and three [69]. They concluded that
the intervention reduced PSH incidence. More recently,
in a prospective quasi-experimental study, 100 patients
discharged into community care from hospital were
given advice to wear a lightweight support garment,
given advice on lifting and hernia prevention, and given
an exercise programme including three types of exer-
cises–abdominal exercises, pelvic tiling, and knee roll-
ing—to do five times and repeat three times a day [70].
The study found that people who developed PSH re-
ported worse QoL than those without PSH [70]. The re-
searchers concluded that the intervention prevented the
development of PSH. However, we believe that it is not
possible to draw definitive conclusions about the effect
of the intervention on PSH prevention because of the
methodological limitations of these studies. This pro-
posed study aims to address these limitations by firstly
developing an intervention to support people to self-
manage as opposed to preventing a bulge/PSH and, sec-
ondly, using a randomised controlled study design to
test the effect of a physical activity intervention on im-
portant clinical endpoints including QoL and bulge/PSH
progression.
Ethical approval and consent to participate The re-
search study has been approved by the North of
Scotland Research Ethics Committee (REC REF 20/NS/
0007).
The ethical principles of ensuring freely given fully in-
formed consent, and the right to withdraw from research
participation will apply.
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